Article Details
Retrieved on: 2022-11-28 08:45:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca will develop and commercialise an oral therapy for the treatment of inflammatory and respiratory diseases with a lead focus on chronic ...
Article found on: www.business-live.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here